Skip to main content
Clinical Trials/CTRI/2022/10/046525
CTRI/2022/10/046525
Completed
Phase 3

A Randomised comparative clinical trial to evaluate the pathya effect of Tila,Masha and Kulattha in Aartava Kshaya

ational Institute of Ayurveda Jaipur0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: N739- Female pelvic inflammatory disease, unspecified
Sponsor
ational Institute of Ayurveda Jaipur
Enrollment
150
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 14, 2023
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • Female patients of age between 18\-40 years.
  • 2\. Duration of flow less than 3 days and/or reduced quantity of flow (using less than 2 pads/day) and/or interval between 2 cycles exceeding more than 35 days.
  • 3\. Patient suffering from oligomenorrhea/ hypomenorrhea and/or PCOD.

Exclusion Criteria

  • Pregnancy and lactation
  • 2\. Any organic pathology of uterus
  • 3\. Physiological infrequent menstruation.
  • 4\. Women taking OCP
  • 5\. Hb less than 7gm% (After screening)
  • 6\. Any systemic disease (Known cases)
  • 7\. Hypo/Hyperthyroidism and other endocrinal disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials